MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
FAME in Perspective
Implications for the strategy and tactics of PCI.
By Stephen G. Ellis, MD
FINESSE Studies Facilitated Reperfusion PCI
October 19, 2009—In the Journal of American College of Cardiology: Cardiovascular Interventions, Stephen G. Ellis, MD, et al published an evaluation of 12-month outcomes of facilitated percutaneous coronary intervention (PCI) in the FINESSE (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events) trial (2009;2:909-916).
One-Year ABSORB III Data Presented for Abbott Vascular's Absorb Bioresorbable Vascular Scaffold
October 12, 2015—Findings from the ABSORB III randomized clinical trial were presented at the TCT 2015, the 27th annual Transcatheter Cardiovascular Therapeutics scientific symposium of the Cardiovascular Research Foundation (CRF), being held October 11–15 in San Francisco, California.
Modern Imaging Modalities
By Ted E. Feldman, MD, FSCAI - Chief Medical Editor
FDA Panel Gives Positive Review of Abbott Vascular's Absorb Bioresorbable Stent
March 15, 2016—Abbott Vascular announced that the Circulatory System Devices Panel of the Medical Devices Advisory Committee of the US Food and Drug Administration (FDA) voted 9 to 0, with one abstention, that the benefits of Abbott’s Absorb fully bioresorbable drug-eluting coronary stent outweigh the risks. The FDA panel also voted on the device's safety and efficacy as a treatment for coronary artery disease.
Perforation Management
An assessment of balloon tamponade, Ringer balloon, covered stents, coils, and thrombin.
By Molly Silkowski, DO, PGY6, and Anbukarasi Maran, MBBS, MD
2007 Focused Update of the ACC/AHA Guidelines
Managing patients with ST-elevation myocardial infarction.
By Eric R. Bates, MD
